Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Ingredion
INGR
$6.26B
| $3.46M | ﹤0.01% |
+30,698
| New | +$3.52M |
|
502
GE Vernova
GEV
$280B
| $3.45M | ﹤0.01% |
3,949
-2,967
| -43% | -$2.31M |
|
503
Coca-Cola Europacific Partners
CCEP
$46.9B
| $3.44M | ﹤0.01% |
37,897
-278
| -0.7% | -$26.7K |
|
504
Tango Therapeutics
TNGX
$4.62B
| $3.4M | ﹤0.01% |
162,399
-25,294
| -13% | -$352K |
|
|
NPKI
505
NPK International
NPKI
$1.21B
| $3.38M | ﹤0.01% |
233,017
+1,046
| +0.5% | +$14.5K |
|
506
State Street Technology Select Sector SPDR ETF
XLK
$118B
| $3.35M | ﹤0.01% |
25,201
-8,809
| -26% | -$1.24M |
|
507
Vanguard Total Bond Market
BND
$158B
| $3.3M | ﹤0.01% |
44,877
-11,430
| -20% | -$848K |
|
508
Simmons First National
SFNC
$3.33B
| $3.29M | ﹤0.01% |
169,280
-13
| -0% | -$260 |
|
509
NextEra Energy
NEE
$184B
| $3.28M | ﹤0.01% |
35,270
+12,448
| +55% | +$1.11M |
|
510
Haleon
HLN
$43.4B
| $3.27M | ﹤0.01% |
327,131
+12,135
| +4% | +$126K |
|
511
Ross Stores
ROST
$70.4B
| $3.25M | ﹤0.01% |
15,005
-3,429
| -19% | -$683K |
|
512
Prosperity Bancshares
PB
$8.71B
| $3.23M | ﹤0.01% |
48,036
-1,034
| -2% | -$72.5K |
|
513
General Mills
GIS
$19.5B
| $3.2M | ﹤0.01% |
85,963
+24,265
| +39% | +$1.05M |
|
514
iShares US Medical Devices ETF
IHI
$3.08B
| $3.17M | ﹤0.01% |
59,364
-31,162
| -34% | -$1.83M |
|
515
AnaptysBio
ANAB
$2.07B
| $3.14M | ﹤0.01% |
56,596
+32
| +0.1% | +$1.72K |
|
516
Vanguard Mega Cap Growth ETF
MGK
$33B
| $3.04M | ﹤0.01% |
41,330
-9,695
| -19% | -$762K |
|
517
PTC Therapeutics
PTCT
$6.75B
| $3.04M | ﹤0.01% |
+44,558
| New | +$3.16M |
|
518
iShares Russell 1000 Value ETF
IWD
$81.8B
| $2.95M | ﹤0.01% |
13,802
-915
| -6% | -$200K |
|
519
Chemed
CHE
$6.53B
| $2.93M | ﹤0.01% |
7,768
-1,988
| -20% | -$851K |
|
520
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
| $2.92M | ﹤0.01% |
27,047
-8
| -0% | -$935 |
|
521
iShares S&P 500 Growth ETF
IVW
$74.3B
| $2.9M | ﹤0.01% |
25,674
+47
| +0.2% | +$5.65K |
|
522
L3Harris
LHX
$53.8B
| $2.9M | ﹤0.01% |
8,389
+1,318
| +19% | +$461K |
|
523
AptarGroup
ATR
$7.97B
| $2.87M | ﹤0.01% |
22,757
-319
| -1% | -$41.6K |
|
524
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.06B
| $2.85M | ﹤0.01% |
97,758
-7,307
| -7% | -$214K |
|
525
Woodside Energy
WDS
$39B
| $2.83M | ﹤0.01% |
118,604
-24,167
| -17% | -$470K |
|
Similar funds
